Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 11/11/20 at 10:30am

The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate to Argentina, while two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to potentially roll out to its citizens in the coming months.

In other news, Denmark is set to cull its 17 million mink population after it was found a mutation of coronavirus in the animal had spread to humans.

1. Denmark set to cull mink population after mutated strain of COVID-19 spreads to humansPublished on 05/11/20

Denmark is set to cull its 17 million mink population after it was found a mutation of coronavirus in the animal had spread to humans.

2. Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patientsPublished on 06/11/20

Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to meet its main goal in the treatment of hospitalised patients with COVID-19 pneumonia and cytokine release syndrome (CRS).

3. Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fundPublished on 09/11/20

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm has invested in companies developing coronavirus antibody cocktails.

4. Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTechPublished on 05/11/20

Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to potentially roll out to its citizens in the coming months.

5. Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford UniPublished on 09/11/20

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with the University of Oxford, to Argentina.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches